Rogier W. Sanders

29.8k total citations · 4 hit papers
212 papers, 11.9k citations indexed

About

Rogier W. Sanders is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Rogier W. Sanders has authored 212 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Virology, 89 papers in Radiology, Nuclear Medicine and Imaging and 82 papers in Immunology. Recurrent topics in Rogier W. Sanders's work include HIV Research and Treatment (167 papers), Monoclonal and Polyclonal Antibodies Research (88 papers) and Immune Cell Function and Interaction (52 papers). Rogier W. Sanders is often cited by papers focused on HIV Research and Treatment (167 papers), Monoclonal and Polyclonal Antibodies Research (88 papers) and Immune Cell Function and Interaction (52 papers). Rogier W. Sanders collaborates with scholars based in Netherlands, United States and United Kingdom. Rogier W. Sanders's co-authors include John P. Moore, Ian A. Wilson, Andrew B. Ward, Albert Cupo, Ben Berkhout, Jean‐Philippe Julien, Per Johan Klasse, Marit J. van Gils, Dennis R. Burton and Dirk Eggink and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Rogier W. Sanders

212 papers receiving 11.8k citations

Hit Papers

Crystal Structure of a So... 2013 2026 2017 2021 2013 2013 2013 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rogier W. Sanders Netherlands 60 8.3k 4.6k 4.6k 4.0k 3.2k 212 11.9k
Michael S. Seaman United States 66 9.7k 1.2× 7.2k 1.6× 4.0k 0.9× 4.5k 1.1× 3.5k 1.1× 224 14.2k
Alexandra Trkola Switzerland 54 9.1k 1.1× 5.6k 1.2× 2.9k 0.6× 4.7k 1.2× 2.3k 0.7× 147 12.0k
Susan Zolla‐Pazner United States 68 11.2k 1.4× 7.1k 1.5× 3.3k 0.7× 5.2k 1.3× 3.7k 1.1× 290 14.8k
James E. Robinson United States 59 11.9k 1.4× 7.3k 1.6× 4.0k 0.9× 6.1k 1.5× 3.6k 1.1× 192 16.4k
Per Johan Klasse United States 56 6.5k 0.8× 3.9k 0.9× 2.6k 0.6× 3.2k 0.8× 2.0k 0.6× 153 9.4k
Robyn L. Stanfield United States 55 5.4k 0.7× 5.5k 1.2× 6.7k 1.5× 2.1k 0.5× 5.4k 1.7× 120 13.5k
James Μ. Binley United States 46 7.6k 0.9× 4.3k 0.9× 2.2k 0.5× 3.2k 0.8× 2.4k 0.7× 80 8.8k
Quentin J. Sattentau United Kingdom 65 10.1k 1.2× 6.9k 1.5× 3.7k 0.8× 4.5k 1.1× 2.2k 0.7× 171 14.7k
Leonidas Stamatatos United States 50 6.2k 0.7× 4.4k 0.9× 2.8k 0.6× 2.6k 0.7× 1.8k 0.6× 132 8.6k
Paul J. Maddon United States 37 9.0k 1.1× 6.4k 1.4× 2.8k 0.6× 4.2k 1.0× 2.1k 0.6× 57 12.4k

Countries citing papers authored by Rogier W. Sanders

Since Specialization
Citations

This map shows the geographic impact of Rogier W. Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier W. Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier W. Sanders more than expected).

Fields of papers citing papers by Rogier W. Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier W. Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier W. Sanders. The network helps show where Rogier W. Sanders may publish in the future.

Co-authorship network of co-authors of Rogier W. Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier W. Sanders. A scholar is included among the top collaborators of Rogier W. Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier W. Sanders. Rogier W. Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gils, Marit J. van, Quentin Pascal, Jonne L. Snitselaar, et al.. (2025). Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates. Nature Communications. 16(1). 2816–2816. 3 indexed citations
2.
Antanasijevic, Aleksandar, Leigh M. Sewall, D Garcia, et al.. (2025). Anti–immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Science Immunology. 10(103). eadp5218–eadp5218. 2 indexed citations
3.
Perrett, Hailee R., Philip J. M. Brouwer, Jonathan Hurtado, et al.. (2023). Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies. Cell Reports. 42(5). 112524–112524. 14 indexed citations
4.
Sastre, Patricia, Lia van der Hoek, Marit J. van Gils, et al.. (2022). Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination. Diagnostic Microbiology and Infectious Disease. 102(4). 115650–115650. 4 indexed citations
5.
Schooten, Jelle van, Marlies M. van Haaren, Hui Li, et al.. (2021). Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. PLoS Pathogens. 17(8). e1009736–e1009736. 12 indexed citations
6.
Brinkkemper, Mitch, Philip J. M. Brouwer, Pauline Maisonnasse, et al.. (2021). A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern. npj Vaccines. 6(1). 146–146. 8 indexed citations
7.
Klasse, Per Johan, Gabriel Ozorowski, Rogier W. Sanders, & John P. Moore. (2020). Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?. Cell Host & Microbe. 27(4). 507–518. 32 indexed citations
8.
Sliepen, Kwinten, Juan García‐Arriaza, Sylvie M. Koekkoek, et al.. (2020). Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV. Vaccines. 8(3). 440–440. 9 indexed citations
9.
Behrens, Anna‐Janina, Abhinav Kumar, Max Medina-Ramírez, et al.. (2018). Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. Journal of Proteome Research. 17(3). 987–999. 16 indexed citations
10.
Velden, Yme U. van der, Julien Villaudy, Kees Weijer, et al.. (2018). Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice. AIDS Research and Human Retroviruses. 34(9). 790–793. 8 indexed citations
11.
Cornelissen, Marion, Zelda Euler, Tom L.G.M. van den Kerkhof, et al.. (2016). The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype. AIDS Research and Human Retroviruses. 32(10-11). 1135–1142. 10 indexed citations
12.
Alexander, Marina R., Rogier W. Sanders, John P. Moore, & Per Johan Klasse. (2015). Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein. AIDS Research and Human Retroviruses. 31(11). 1160–1165. 11 indexed citations
13.
Sok, Devin, Marit J. van Gils, Matthias Pauthner, et al.. (2014). A Recombinant HIV Envelope Trimer Selects for Quaternary Dependent Antibodies Targeting the Trimer Apex. AIDS Research and Human Retroviruses. 30(S1). A7–A8. 3 indexed citations
14.
Julien, Jean‐Philippe, Albert Cupo, Devin Sok, et al.. (2013). Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer. Science. 342(6165). 1477–1483. 640 indexed citations breakdown →
15.
Lyumkis, Dmitry, Jean‐Philippe Julien, Natalia de Val, et al.. (2013). Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer. Science. 342(6165). 1484–1490. 527 indexed citations breakdown →
16.
Melchers, Mark, Ilja Bontjer, Tommy Tong, et al.. (2011). Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses. Journal of Virology. 86(5). 2488–2500. 39 indexed citations
17.
Banerjee, Kaustuv, Elizabeth Michael, Dirk Eggink, et al.. (2011). Occluding the Mannose Moieties on Human Immunodeficiency Virus Type 1 gp120 with Griffithsin Improves the Antibody Responses to Both Proteins in Mice. AIDS Research and Human Retroviruses. 28(2). 206–214. 28 indexed citations
18.
Klasse, Per Johan, Rogier W. Sanders, Andrea Cerutti, & John P. Moore. (2011). How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?. AIDS Research and Human Retroviruses. 28(1). 1–15. 64 indexed citations
19.
Banerjee, Kaustuv, Per Johan Klasse, Rogier W. Sanders, et al.. (2010). IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines. AIDS Research and Human Retroviruses. 26(4). 445–458. 84 indexed citations
20.
Sanders, Rogier W., et al.. (2004). Evolutionary Repair of HIV Type 1 gp41 with a Kink in the N-Terminal Helix Leads to Restoration of the Six-Helix Bundle Structure. AIDS Research and Human Retroviruses. 20(7). 742–749. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026